Establishment and characterization of an in vitro 3D ovarian cancer model for drug screening assays (2020)
- Authors:
- USP affiliated authors: MARCHETTI, JULIANA MALDONADO - FCFRP ; ANTONIETTO, KAMILLA SWIECH - FCFRP ; TOFANI, LARISSA BUENO - FCFRP ; ABRIATA, JULIANA PALMA - FCFRP ; LUIZ, MARCELA TAVARES - FCFRP
- Unidade: FCFRP
- DOI: 10.1002/btpr.3034
- Subjects: NEOPLASIAS OVARIANAS; FÁRMACOS; BIOTECNOLOGIA
- Keywords: 3D culture; Cell-based platform; Drug screening; Ovarian cancer; Spheroids
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Biotechnology Progress
- ISSN: 8756-7938
- Volume/Número/Paginação/Ano: v. 36, n. 6, art. e3034, p. 1-11, 2020
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
TOFANI, Larissa Bueno et al. Establishment and characterization of an in vitro 3D ovarian cancer model for drug screening assays. Biotechnology Progress, v. 36, n. 6, p. 1-11, 2020Tradução . . Disponível em: https://doi.org/10.1002/btpr.3034. Acesso em: 28 dez. 2025. -
APA
Tofani, L. B., Abriata, J. P., Luiz, M. T., Marchetti, J. M., & Swiech, K. (2020). Establishment and characterization of an in vitro 3D ovarian cancer model for drug screening assays. Biotechnology Progress, 36( 6), 1-11. doi:10.1002/btpr.3034 -
NLM
Tofani LB, Abriata JP, Luiz MT, Marchetti JM, Swiech K. Establishment and characterization of an in vitro 3D ovarian cancer model for drug screening assays [Internet]. Biotechnology Progress. 2020 ; 36( 6): 1-11.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1002/btpr.3034 -
Vancouver
Tofani LB, Abriata JP, Luiz MT, Marchetti JM, Swiech K. Establishment and characterization of an in vitro 3D ovarian cancer model for drug screening assays [Internet]. Biotechnology Progress. 2020 ; 36( 6): 1-11.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1002/btpr.3034 - Docetaxel-loaded folate-modified TPGS-transfersomes for glioblastoma multiforme treatment
- The use of TPGS in drug delivery systems to overcome biological barriers
- Development, characterization and biological in vitro assays of paclitaxel-loaded PCL polymeric nanoparticles
- Targeted liposomes: a nonviral gene delivery system for cancer therapy
- Gene therapy based on lipid nanoparticles as non-viral vectors for glioma treatment
- Highlights in targeted nanoparticles as a delivery strategy for glioma treatment
- Generation of a three-dimensional in vitro ovarian cancer co-culture model for drug screening assays
- In vitro evaluation of folate-modified PLGA nanoparticles containing paclitaxel for ovarian cancer therapy
- Epirubicin: biological properties, analytical methods, and drug delivery nanosystems
- PCL-TPGS polymeric nanoparticles for docetaxel delivery to prostate cancer: development, physicochemical and biological characterization
Informações sobre o DOI: 10.1002/btpr.3034 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003133959.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
